These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17494068)

  • 21. Virus entry mediated by hepatitis B virus envelope proteins.
    Taylor JM
    World J Gastroenterol; 2013 Oct; 19(40):6730-4. PubMed ID: 24187448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus.
    Chouteau P; Le Seyec J; Cannie I; Nassal M; Guguen-Guillouzo C; Gripon P
    J Virol; 2001 Dec; 75(23):11565-72. PubMed ID: 11689638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
    Abou-Jaoudé G; Sureau C
    J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of hepatitis B virus envelope proteins in assembly and infectivity of human hepatitis delta virus.
    Sureau C; Lanford R
    Prog Clin Biol Res; 1993; 382():45-51. PubMed ID: 8502715
    [No Abstract]   [Full Text] [Related]  

  • 25. Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.
    Lambert C; Prange R
    Virol J; 2007 May; 4():45. PubMed ID: 17537250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.
    Bruss V; Hagelstein J; Gerhardt E; Galle PR
    Virology; 1996 Apr; 218(2):396-9. PubMed ID: 8610467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein.
    Hartmann-Stühler C; Prange R
    J Virol; 2001 Jun; 75(11):5343-51. PubMed ID: 11333915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.
    Sureau C; Fournier-Wirth C; Maurel P
    J Virol; 2003 May; 77(9):5519-23. PubMed ID: 12692255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of the interaction between the envelope protein domains and the core protein of human hepatitis B virus.
    Choi KJ; Lim CW; Yoon MY; Ahn BY; Yu YG
    Biochem Biophys Res Commun; 2004 Jul; 319(3):959-66. PubMed ID: 15184075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts.
    Schieck A; Schulze A; Gähler C; Müller T; Haberkorn U; Alexandrov A; Urban S; Mier W
    Hepatology; 2013 Jul; 58(1):43-53. PubMed ID: 23292963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the envelope proteins by a metalloproteinase enables attachment and entry of the hepatitis B virus into T-lymphocyte.
    Budkowska A; Maillard P; Theret N; Groh F; Possehl C; Topilko A; Crainic R
    Virology; 1997 Oct; 237(1):10-22. PubMed ID: 9344903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between human albumin polymers and the envelope polypeptide of hepatitis B virus (P31) containing the translation product of the pre-S2 region.
    Fukuda M; Akahane Y; Mayumi M
    Jpn J Exp Med; 1987 Apr; 57(2):125-9. PubMed ID: 3669400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.
    Sureau C
    Methods Mol Biol; 2010; 640():463-73. PubMed ID: 20645068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the binding ability of pre-S1 and S2 proteins of hepatitis B virus to human serum albumin.
    Hu KQ; Yu ZQ; Li FH; Hao LJ
    Hepatogastroenterology; 1990 Jun; 37(3):338-41. PubMed ID: 2373467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
    Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
    Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein.
    Awe K; Lambert C; Prange R
    FEBS Lett; 2008 Sep; 582(21-22):3179-84. PubMed ID: 18708056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.
    Fernholz D; Galle PR; Stemler M; Brunetto M; Bonino F; Will H
    Virology; 1993 May; 194(1):137-48. PubMed ID: 8480417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the minimal distance between the matrix and transmembrane domains of the large hepatitis B virus envelope protein.
    Kluge B; Schläger M; Pairan A; Bruss V
    J Virol; 2005 Jun; 79(12):7918-21. PubMed ID: 15919948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.